COVID-19 vaccine: Risk of inequality and failure of public health strategies.
作者信息
Cioffi A, Cioffi F
机构信息
Department of Anatomical, Histological, Forensic and Orthopaedic Sciences, Sapienza University of Rome, Rome, Italy.
Fertilitas Day Surgery Reproductive Medicine, Salerno, Italy.
出版信息
Ethics Med Public Health. 2021 Jun;17:100653. doi: 10.1016/j.jemep.2021.100653. Epub 2021 Mar 19.
Abstract
摘要
相似文献
1
COVID-19 vaccine: Risk of inequality and failure of public health strategies.新冠疫苗：不平等风险与公共卫生策略的失灵
Ethics Med Public Health. 2021 Jun;17:100653. doi: 10.1016/j.jemep.2021.100653. Epub 2021 Mar 19.
2
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
3
SARS-CoV-2 Vaccine Hesitancy in a Sample of US Adults: Role of Perceived Satisfaction With Health, Access to Healthcare, and Attention to COVID-19 News.美国成年人对 SARS-CoV-2 疫苗的犹豫：对健康满意度、获得医疗保健的机会和对 COVID-19 新闻关注度的作用。
Front Public Health. 2021 Apr 29;9:665724. doi: 10.3389/fpubh.2021.665724. eCollection 2021.
4
SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.中东和北非地区的 SARS-CoV-2 监测：纵向趋势分析。
J Med Internet Res. 2021 Jan 15;23(1):e25830. doi: 10.2196/25830.
5
From Health Disparities to Hotspots to Public Health Strategies: The Impact of the COVID-19 Pandemic in North Carolina.从健康差距到热点再到公共卫生策略：COVID-19 大流行对北卡罗来纳州的影响。
N C Med J. 2021 Jan-Feb;82(1):37-42. doi: 10.18043/ncm.82.1.37.
6
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.CEPI/BC 2020 年 3 月 12-13 日会议共识总结报告：评估 COVID-19 疫苗引起疾病增强的风险。
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
7
SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward.SARS-CoV-2（COVID-19）疫苗的开发和生产：一条合乎道德的前进道路。
Camb Q Healthc Ethics. 2021 Jan;30(1):59-68. doi: 10.1017/S096318012000047X. Epub 2020 Jun 5.
8
Scrutinizing the SARS-CoV-2 protein information for designing an effective vaccine encompassing both the T-cell and B-cell epitopes.深入研究 SARS-CoV-2 蛋白信息，设计一种既包含 T 细胞表位又包含 B 细胞表位的有效疫苗。
Infect Genet Evol. 2021 Jan;87:104648. doi: 10.1016/j.meegid.2020.104648. Epub 2020 Nov 29.
9
A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2.一种针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的可扩展局部载体候选疫苗。
Vaccines (Basel). 2020 Aug 24;8(3):472. doi: 10.3390/vaccines8030472.
10
COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies.COVID-19 疫苗：管道疫苗的最新更新、设计和开发策略。
Eur J Pharmacol. 2021 Feb 5;892:173751. doi: 10.1016/j.ejphar.2020.173751. Epub 2020 Nov 25.
引用本文的文献
1
Quantifying Changes in Vaccine Coverage in Mainstream Media as a Result of the COVID-19 Outbreak: Text Mining Study.量化新冠疫情导致的主流媒体中疫苗接种覆盖率变化：文本挖掘研究
JMIR Infodemiology. 2022 Sep 20;2(2):e35121. doi: 10.2196/35121. eCollection 2022 Jul-Dec.
2
COVID-19 vaccine inequality: A global perspective.新冠疫苗不平等：全球视角
J Glob Health. 2022 Oct 14;12:03072. doi: 10.7189/jogh.12.03072.
3
Covid-19 vaccine dissemination: A public health ethical evaluation of Pennsylvania's plan during Phase 1A.新冠疫苗的分发：对宾夕法尼亚州1A阶段计划的公共卫生伦理评估
Ethics Med Public Health. 2022 Oct;24:100815. doi: 10.1016/j.jemep.2022.100815. Epub 2022 Jun 17.
4
Achieving Equitable Access to Medicines and Health Services: A COVID-19-time Recalled Matter.实现药品和医疗服务的公平可及：新冠疫情期间唤起的议题
Iran J Pharm Res. 2021 Fall;20(4):450-466. doi: 10.22037/ijpr.2021.116120.15709.
5
Eight Good Reasons for Careful Monitoring and Evaluation of the Vaccine Campaign against COVID-19: Lessons Learned through the Lombardy Experience for Dealing with Next Challenges.八项谨慎监测和评估新冠疫苗接种运动的充分理由：伦巴第大区应对下一轮挑战的经验教训
Int J Environ Res Public Health. 2022 Jan 19;19(3):1073. doi: 10.3390/ijerph19031073.
6
Will the high acceptance rate of coronavirus disease 2019 vaccine in Morocco accelerate the recovery of neurosurgical practice?2019冠状病毒病疫苗在摩洛哥的高接种率会加速神经外科手术业务的恢复吗？
Surg Neurol Int. 2021 Sep 30;12:486. doi: 10.25259/SNI_690_2021. eCollection 2021.
本文引用的文献
1
How COVID vaccines are being divvied up around the world.新冠疫苗在全球是如何分配的。
Nature. 2020 Nov 30. doi: 10.1038/d41586-020-03370-6.
2
Intensive and pharmacological care in times of COVID-19: A "special ethics" for emergency?COVID-19 时期的强化与药物治疗：急诊的“特殊伦理”？
BMC Med Ethics. 2020 Nov 19;21(1):117. doi: 10.1186/s12910-020-00562-7.
3
COVID-19 and healthcare-associated infections.新型冠状病毒肺炎和医源性感染。
Int J Risk Saf Med. 2020;31(4):181-182. doi: 10.3233/JRS-200056.
4
CoViD-19 and psychiatry: can mental illness justify further exceptions to the obligation to stay at home?新冠病毒和精神病学：精神疾病是否可以成为进一步免除居家义务的理由？
Riv Psichiatr. 2020 Jul-Aug;55(4):245-249. doi: 10.1708/3417.34002.
5
Covid-19 and medical liability: A delicate balance.新冠疫情与医疗责任：微妙的平衡。
Med Leg J. 2020 Dec;88(4):187-188. doi: 10.1177/0025817220935879. Epub 2020 Jul 3.
6
COVID-19 and abortion: The importance of guaranteeing a fundamental right.COVID-19 与堕胎：保障基本权利的重要性。
Sex Reprod Healthc. 2020 Oct;25:100538. doi: 10.1016/j.srhc.2020.100538. Epub 2020 Jun 6.
7
Public and Private Health Services: Wait Times for Health Services and the Risk of Inequality from the Italian Perspective.公共与私人医疗服务：从意大利视角看医疗服务等待时间与不平等风险
Popul Health Manag. 2021 Jun;24(3):314-315. doi: 10.1089/pop.2020.0091. Epub 2020 May 28.
8
Coronavirus Disease 2019: Is Everything Lawful to Create an Effective Vaccine?2019年冠状病毒病：为研发有效疫苗所采取的一切措施都合法吗？
J Infect Dis. 2020 Jun 16;222(1):169. doi: 10.1093/infdis/jiaa216.
Zotero 插件